3858 results for «2354»
3858 results
Transcatheter management of structural defects
20 May 2025 – From EuroPCR 2025
Explore the transcatheter management of structural cardiac defects with challenging clinical scenarios including ventricular septal ruptures and post-TAVI complications. This session emphasizes multidisciplinary approaches and strategic planning to avert catastrophic outcomes and optimize patient care.
Symplicity Spyral renal denervation: more insights from clinical practice
21 May 2025 – From EuroPCR 2025
Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...
The future is now: QFR and RMS to optimise coronary artery disease patient management
20 May 2025 – From EuroPCR 2025
See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...
Techniques for the treatment of left main lesions
20 May 2025 – From EuroPCR 2025
Discover contemporary techniques for treating left main coronary artery lesions with a focus on ultra low-contrast PCI, management of calcified Medina 0-0-1 lesions, and troubleshooting intravascular lithotripsy. This session provides practical insights into complex lesion treatment to enhance safety and efficacy.
The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients
22 May 2025 – From EuroPCR 2025
How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?
This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.
Follow the discussion to understand...
Invasive treatment of refractory angina
20 May 2025 – From EuroPCR 2025
Explore invasive treatment options for refractory angina through clinical case presentations emphasizing coronary physiology guidance, coronary microvascular disease management, and innovative therapies such as coronary sinus reducer implantation. This session highlights provocative test-guided approaches to optimize patient outcomes.
The Landmark RCT - One-year results
21 May 2025 – From EuroPCR 2025
This session presents a detailed analysis of a landmark randomized controlled trial evaluating the Myval transcatheter aortic valve implantation (TAVI) system among other contemporary transcatheter valves. The discussion centers on one-year clinical outcomes, with a particular focus on women, patients with small aortic annuli, and those...
The new global era of patient care with CathWorks FFRangio
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights how CathWorks FFRangio is reshaping coronary physiology assessment worldwide. Through case-based experience and real-world data, it showcases the integration of FFRangio into routine clinical workflows—from early adoption at Clinique Pasteur in Toulouse to implementation across the UK. The session also presents...
The role of large-bore thrombectomy in my approach to pulmonary embolism management
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of the use of large-bore thrombectomy in the management of pulmonary embolism. It highlights key clinical considerations for intervention, including the potential to reduce fatal events, prevent long-term complications, and optimize cost-effectiveness in eligible patients. A real-life case involving a 65-year-old patient...
Transforming PCI: mastering the implementation of drug-eluting balloons
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and...
Treat calcium right the first time: new considerations for PCI planning and device selection to optimise outcomes
21 May 2025 – From EuroPCR 2025
Watch this EuroPCR 2025 session to learn how intravascular lithotripsy (IVL) is transforming the management of coronary artery calcification (CAC). Discover the new CALC roadmap, a comprehensive framework guiding device selection and treatment strategies based on calcium burden, anatomy, and patient gender. Follow a real-world clinical...
Treating complex CAD indications with sirolimus coated balloon: evidence and performance
22 May 2025 – From EuroPCR 2025
Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...
Clinical outcomes of left main PCI
21 May 2025 – From EuroPCR 2025
This session reviews clinical outcomes of left main PCI in various contexts including ACS, complex lesion risk stratification with BCIS-CHIP score, and spontaneous coronary artery dissection. It also compares double-stent techniques and examines five-year results to guide clinical decision-making.
Through decisions in complex left main PCI - Isolated ostial left circumflex
21 May 2025 – From EuroPCR 2025
Navigate complex isolated ostial left circumflex lesions with a focus on the integration of imaging and physiological assessment. Learn treatment options and optimisation strategies to improve long-term outcomes in left main PCI through detailed case presentations and expert guidance.
New devices for structural interventions
21 May 2025 – From EuroPCR 2025
Discover emerging devices transforming structural heart interventions. This session highlights biomimetic valve designs, new transcatheter aortic valve systems, novel devices for aortic insufficiency, leaflet resection, left atrial appendage closure, and short self-expanding TAVR valves with promising early results.
How should I treat this vulnerable plaque?
21 May 2025 – From EuroPCR 2025
Learn to identify and manage vulnerable plaque using intracoronary imaging. This session covers detection techniques, clinical implications, current evidence for treatment, and case-based insights to improve patient outcomes through targeted intervention.
Challenging vascular access and closure management
21 May 2025 – From EuroPCR 2025
Address challenging vascular access and closure management in complex TAVI cases. This session covers the selection of femoral access, use of PTA and intravascular lithotripsy, and strategies to manage closure failure with illustrative real-world cases.
Valve-in-valve TAVI
21 May 2025 – From EuroPCR 2025
Explore valve-in-valve TAVI strategies for patients with degenerated surgical valves, focusing on small aortic annuli. This session covers the impact of valve design and implant techniques, valve fracturing methods, procedural outcomes of repeat TAVI, and mid-to-long-term results from the ACCURATE NEO 2 study.
DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT
21 May 2025 – From EuroPCR 2025
Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.
ACS with normal coronary arteries: angiography done, job done?
21 May 2025 – From EuroPCR 2025
Understand the clinical significance of MINOCA and learn diagnostic strategies integrating invasive and non-invasive tests to identify underlying etiologies. This session provides therapeutic insights tailored to specific MINOCA endotypes through illustrative cases.
